PET tracers for 5-HT1A receptors and uses thereof

Drug Discovery Today

Volumn 12, Issue 17-18, 2007, Pages 748-756

  Kumar, J S Dileep ^a   Mann, J John ^a  

^a New York State Psychiatric Institute ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 DIPROPYLAMINO 8 HYDROXYTETRALIN; 2,3,4,5,6,7 HEXAHYDRO 1 [4 [1 [4 (2 METHOXYPHENYL)PIPERAZINYL]] 2 PHENYLBUTYRYL]AZEPINE; 4 (2 METHOXYPHENYL) 1 [2 (N 2 PYRIDINYL) 4 FLUOROBENZAMIDO)ETHYL]PIPERAZINE; AUTORECEPTOR; AZEPINE DERIVATIVE; CARBON 11; CPC 222; CYCLOHEXANE DERIVATIVE; FLUORINE 18; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; N [2 [4 (2 METHOXYPHENYL)PIPERAZINYL]ETHYL] N (2 PYRIDYL) N (4 FLUOROMETHYLCYCLOHEXANE)CARBOXAMIDE; NOR N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; PIPERAZINE DERIVATIVE; POSTSYNAPTIC RECEPTOR; PRESYNAPTIC RECEPTOR; RADIOLIGAND; SEROTONIN; SEROTONIN 1A AGONIST; SEROTONIN 1A RECEPTOR; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; BRAIN CORTEX; BULIMIA; DEPRESSION; EPILEPSY; HUMAN; IN VIVO CULTURE; LIGAND BINDING; MENTAL DISEASE; PANIC; PARKINSON DISEASE; PATHOPHYSIOLOGY; POSITRON EMISSION TOMOGRAPHY; POSTSYNAPTIC MEMBRANE; PRESYNAPTIC NERVE; PROTEIN LOCALIZATION; QUANTITATIVE ANALYSIS; RECEPTOR DENSITY; REVIEW; SCHIZOPHRENIA; SEROTONIN RELEASE; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SUICIDAL BEHAVIOR; TISSUE DISTRIBUTION;

AUTORECEPTORS; BRAIN; CARBON RADIOISOTOPES; FLUORINE RADIOISOTOPES; HUMANS; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; RECEPTOR, SEROTONIN, 5-HT1A; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 34548413531     PISSN: 13596446     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.drudis.2007.07.008     Document Type: Review

References (113)

1. 1A receptors. Pharmacol. Biochem. Behav. 71 (2002) 533-554
2. 1A receptor functions in brain following agonist or antidepressant administration. Life Sci. 72 (2003) 1665-1682
3. Neumeister A., et al. Reduced serotonin type 1A receptor binding in panic disorder. J. Neurosci. 24 (2004) 589-591
4. 1A receptors, serotonin transporter binding and serotonin transporter mRNA expression in the brainstem of depressed suicide victims. Neuropsychopharmacology 25 (2001) 892-903
5. Arango V., et al. Genetics of the serotonergic system in suicidal behavior. J. Psychiatric Res. 37 (2003) 375-386
6. 1A receptor binding in major depression is related to psychic and somatic anxiety. Biol. Psychiatry 58 (2005) 947-954
7. 18F]MPPF-PET study. Brain 127 (2004) 900-913
8. 1A receptor binding in bulimia nervosa. Biol. Psychiatry 55 (2004) 871-873
9. 1A receptors in the living brain of Alzheimer's disease patients. Proc. Natl. Acad. Sci. 103 (2006) 702-707
10. Kuenzel H.E., et al. Changes in sleep electroencephalogram and nocturnal hormone secretion after administration of the antidyskinetic agent sarizotan in healthy young male volunteers. Psychopharmacology 180 (2005) 327-332
11. 1A receptor binding in the temporal cortex correlates with aggressive behavior in Alzheimer disease. Brain Res. 974 (2003) 82-87
12. 3H]8-OH-DPAT and demonstration of increased binding in the frontal cortex in schizophrenia. Neurochem. Int. 30 (1997) 565-574
13. 11C]WAY100635. Brain Res. 745 (1997) 96-108
14. Arango V., et al. Localized alterations in pre- and postsynaptic serotonin binding sites in the ventrolateral prefrontal cortex of suicide victims. Brain Res. 688 (1995) 121-133
15. 11C]WAY100635 Positron Emission Tomography Study. Biol. Psychiatry 59 (2006) 106-113
16. 11C]WAY100635. Brain Res. 954 (2002) 173-182
17. 1A receptors: in vivo development of some new analogues of WAY. Nucl. Med. Biol. 27 (2000) 449-455
18. 1A receptor PET radioligands. Nucl. Med. Biol. 27 (2000) 441-447
19. 1A receptors in vivo. Progr. Med. Chem. 38 (2001) 189-247
20. 1A) receptors in the central nervous system. Eur. J. Nucl. Med. 28 (2001) 113-129
21. 1A receptor antagonist. Behav. Brain Res. 73 (1996) 337-353
22. 1A receptor antagonist. Brain Res. 673 (1995) 217-225
23. 1A receptors in rat brain membranes. Eur. J. Pharmacol. 288 (1995) 173-186
24. 11C]WAY1000635, in monkey and human plasma by HPLC: comparison of the behaviour of an identified radioactive metabolite with parent radioligand in monkey using PET. Nucl. Med. Biol. 23 (1996) 627-634
25. 11C]WAY100635. Brain Res. 745 (1997) 96-108
26. 1A autoreceptors in the midbrain of suicide victims with major depression-postmortem evidence for decreased serotonin activity. J. Neurosci. 18 (1998) 7394-7401
27. 1A receptor binding in depression. Biol. Psychiatry 46 (1999) 1375-1387
28. 1A receptor. Brain Res. 895 (2001) 9-17
29. 1A receptors in normal male volunteers: normative data and relationship to methodological, demographic, physiological, and behavioral variables. Neuroimage 15 (2002) 620-632
30. 11C]WAY100635 and PET. Neuropsychopharmacology 24 (2001) 522-530
31. 11C]WAY 100635. Mol. Psychiatry 9 (2004) 386-392
32. 1A receptor sites in human brain as function of age in healthy humans. Neuropsychopharmacology 30 (2007) 1-8
33. 11C]WAY100635 in humans: Comparison of arterial and reference tissue input functions. J. Cereb. Blood Flow Metab. 20 (2000) 1111-1133
34. 1A receptor binding and treatment response in late-life depression. Neuropsychopharmacology 29 (2004) 2258-2265
35. 1A receptor number. Biol. Psychiatry 50 (2001) 668-676
36. 1A receptor binding potential during a major depressive episode predicts poor treatment response: preliminary data from a naturalistic study. Neuropsychopharmacology 31 (2006) 1745-1749
37. 1A receptor binding in social anxiety disorder. Biol. Psychiatry 61 (2007) 1081-1089
38. 1A receptor binding in type 2 diabetes: a positron emission tomography study. Brain Res. 927 (2002) 97-103
39. 1A receptor binding in human temporal lobe epilepsy. Neurology 62 (2004) 1343-1351
40. 11C]WAY100635. Epilepsy Res. 73 (2007) 111-118
41. 1A receptor binding in juvenile myoclonic epilepsy. Arch. Neurol. 62 (2005) 946-950
42. 11C]WAY100635. Arch. Gen. Psychiatry 62 (2005) 1032-1041
43. 1A receptors at different phases of the menstrual cycle in women with premenstrual dysphoria. Psychiatry Res. Neuroimaging 148 (2006) 185-193
44. Gurevich E.V., and Joyce J.N. Alterations in the cortical serotonergic system in schizophrenia: a postmortem study. Biol. Psychiatry 42 (1997) 529-545
45. 1A receptors in prefrontal and temporal cortices of brains from patients with chronic schizophrenia. Life Sci. 48 (1991) 355-363
46. 2A receptor mRNAs and binding site densities are differentially altered in schizophrenia. Neuropsychopharmacology 15 (1996) 442-455
47. 1A receptors in ventral prefrontal cortex in schizophrenia. Biol. Psychiatry 39 (1996) 919-928
48. 11C]WAY100635. Arch. Gen. Psychiatry 59 (2002) 514-520
49. 1A receptor binding in amygdala of schizophrenia. Biol. Psychiatry 55 (2006) 439-444
50. 11C]WAY100635. Psychopharmacology 189 (2006) 155-164
51. 11C]WAY100635. Biol. Psychiatry 57 (2005) 239-246
52. 11C-WAY100635 PET study. Neurology 25 (2003) 601-605
53. 1A receptor changes in sporadic ALS. Brain 128 (2005) 896-905
54. 1A receptor in schizophrenia and during clozapine treatment. J. Psychopharmacol 18 (2004) 346-354
55. 1A receptor occupancy in the monkey brain. Neuropsychopharmacology 22 (2001) 422-429
56. 1A receptor occupancy with J Psychopharmacology, 155, 193-197
57. Rabiner E.A., et al. Pindolol augmentation of selective serotonin reuptake inhibitors: PET evidence that the dose used in clinical trials is too low. Am. J Psychiatry 158 (2001) 2080-2082
58. 11C]WAY 100635 and positron emission tomography in humans. Neuropsychopharmacology 24 (2001) 209-229
59. 11C][O-methyl-3H]-n-(2-(4-(2-methoxyphenyl)-1-piperazinyl)et hyl)-N-(2-pyridinyl)cyclohexanecarboxamide trihydrochloride (WAY100635) positron emission tomography study in humans. J. Pharmacol. Exp. Ther. 301 (2002) 1144-1150
60. 1A receptor. Neuropsychopharmacology 29 (2004) 847-859
61. 11C]WAY100635. Nucl. Med. Biol. 27 (2000) 509-513
62. 1A receptors in vitro and in vivo. Eur. J. Nucl. Med. 25 (1998) 338-346
63. 11C]WAY-100635 in the human brain. J. Nucl. Med. 43 (2002) 292-303
64. 11C-carbonyl]WAY100635. Nucl. Med. Biol. 26 (1999) 815-819
65. 11C]desmethyl-WAY-100635. Appl. Rad. Isotop. 62 (2005) 721-727
66. 1A receptors in humans. Synapse 25 (1997) 147-154
67. 1A receptors in animal and human brain. Neuropharmacology 52 (2007) 695-707
68. 18F]MPPF binding in the rat hippocampus. J. Nucl. Med. 44 (2003) 1495-1501
69. 18F]MPPF by the electrically evoked serotonin release in the rat hippocampus. Synapse 49 (2003) 239-245
70. 18F]MPPF binding in the rat dorsal raphe nucleus. Eur. J. Nucl. Med. Mol. Imaging 29 (2002) 1237-1247
71. 18F]MPPF binding: a continuous infusion PET study in conscious monkeys. Synapse 59 (2005) 18-26
72. 18F]MPPF positron emission tomography study. Biol. Psychiatry 56 (2004) 587-591
73. 18F]MPPF binding. Synapse 46 (2002) 108-115
74. 1A receptor binding sites in the cat brain. J. Chem. Neuroanatomy 31 (2006) 226-232
75. 18F]MPPF PET study in narcolepsy. NeuroImage 30 (2006) 341-348
76. 1A ligand for PET, in rats. Nucl. Med. Biol. 33 (2006) 667-675
77. Lang L., et al. Synthesis and in vivo biodistribution of F-18 labeled 3-cis-, 3-trans-, 4-cis-, and 4-trans-fluorocyclohexane derivatives of WAY 100635. Bioorg. Med. Chem. 14 (2006) 3737-3748
78. 1A receptor binding in panic disorder. J. Neurosci. 24 (2004) 589-591
79. 1A receptors are reduced in temporal lobe epilepsy after partial-volume correction. J. Nucl. Med. 46 (2005) 1128-1135
80. 1A receptor binding in patients with temporal lobe epilepsy. Neurology 11 (2003) 749-756
81. 1A receptor binding measured by positron emission tomography. Epilepsia 47 (2006) 499-503
82. 1A receptor binding in patients with posttraumatic stress disorder. Am. J. Psychiatry 162 (2005) 382-385
83. 18F]FCWAY and improvement by successful inhibition of radioligand defluorination with miconazole. J. Nucl. Med. 47 (2006) 345-353
84. 1A receptors with PET: WAY100635 and analogues. Nucl. Med. Biol. 27 (2000) 463-466
85. 11C]CPC-222. Nucl. Med. Commun. 18 (1997) 1130-1134
86. 1A receptor radioligand behavior in monkey. Mol. Imaging Biol. 7 (2005) 209-219
87. 11C](R)-(-)-RWAY. Synapse 60 (2006) 510-520
88. 11C](R)-(-)-RWAY. Synapse 61 (2006) 96-105
89. 11C](R)-(2)-RWAY: radiometabolite(s) likely confound brain measurements. Synapse 61 (2007) 469-477
90. 18F]-labeled mefway, in rodents and imaging by PET in a nonhuman primate. J. Nucl. Med. 47 (2006) 1697-1706
91. 1A receptors. Bioorg. Chem. 26 (1998) 91-102
92. 1A receptors by positron emission tomography(PET). J. Label. Compd. Radiopham. 48 (2005) 301-315
93. 1 receptor subtypes exhibit distinct G protein coupling behaviors in membranes from Sf9 cells. Biochemistry 36 (1997) 12930-12938
94. 1A receptor agonist-antagonist binding affinity difference as a measure of intrinsic activity in recombinant and native tissue systems. Br. J. Pharmacol. 130 (2000) 1108-1114
95. 1A receptors in rat brain membranes. Eur. J. Pharmacol. 288 (1995) 173-186
96. 1A sites in the rat brain. In vitro binding and autoradiographic studies. J. Pharmacol. Exp. Ther. 244 (1988) 751-759
97. 1A receptors in the central nervous system. C R Acad. Sci. III 306 (1988) 147-152
98. 1A receptor ligand. J. Med. Chem. 36 (1993) 3161-3165
99. 1A agonist for PET. J. Label. Compd. Radiopharm. 35 (1994) S675-S677
100. 11C]LY274601. Life Sci. 63 (1998) 1533-1542
101. 1A agonists as radioligands: failure of G protein-coupled receptor agonists as in vivo imaging agents. J. Label. Compd. Radiopharm. 40 (1997) 563-564
102. 1A receptors: synthesis and evaluation of its biodistribution in monkey with PET. J. Label. Compd. Radiopharm. 44 (1995) S179
103. 1A) receptor ligand. J. Nucl. Med. 36 (1995) 163P
104. 1A receptor ligand. Nucl. Med. Biol. 29 (2002) 657-663
105. Hwang D.R., et al. 1-[2[(4-[F-18]fluorobenzamido-1-ethyl]4-(1,2,3,4-tetrahydronaphth-1-yl)- piperidine (FBP). J. Label. Compd. Radiopharm. 44 (2001) S179
106. 1A receptor. J. Label. Compd. Radiopharm. 47 (2004) 531-542
107. 1A receptor. Nucl. Med. Biol. 28 (2001) 639-643
108. 1A receptor agonist, and its in vivo evaluation in anaesthetized rat and in awake cat. Nucl. Med. Biol. 30 (2003) 541-546
109. 1A receptor agonist, 1-[2-(4-fluorobenzoylamino)ethyl]-4-(7-methoxynaphthyl)piperazine (S14506), with carbon-11 or fluorine-18. J. Label. Compd. Radiopharm. 48 (2006) 971-981
110. 11C]-2-[4-[4-(7-methoxy-1-naphthalenyl)-1-piperazin yl]butyl]-4-methyl-2H-[1,2,4]triazine-3,5-dione: a novel 5-HT1A receptor agonist positron emission tomography ligand. J. Med. Chem. 49 (2006) 125-134
111. Kumar, J.S.D, and Mann, J.J. (2006) Radiolabeled piperizine compounds and uses thereof. WO 2006083424
112. 11C] 2-{4-[4-(3-methoxyphenyl)piperazin-1-yl]-butyl}-4-methyl-2H-[1,2,4]-tria zine-3,5-dione: A novel agonist 5-HT1A receptor PET ligand. Bioorg. Med. Chem. Lett. 16 (2006) 2101-2104
113. 11C]2-(4-(2-methoxyphenyl)piperazin-1-yl)butyl)-4-m ethyl-1,2,4-triazine-3,5(2H,4H)- dione in Nonhuman Primates. Eur. J. Nuc. Med. Mol. Imaging 34 (2007) 1050-1060